Compare Simon Property Group Inc (SPG) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Simon Property Group Inc vs Tenet Healthcare Corporation — how do they compare? Simon Property Group Inc trades at $199.6 (market cap $63.93B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Simon Property Group Inc is far larger — about 3.1× Tenet Healthcare Corporation's market cap, and Simon Property Group Inc pays a 4.5% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Simon Property Group Inc for 99 Days and Tenet Healthcare Corporation for 15 Days on average.
| SPG | THC | |
|---|---|---|
Market Cap | $63.93B | $20.92B |
Volume | 1,228,229 | 455,764 |
Sector | Real Estate | Health |
52-Week High | $236.70 | $280.77 |
52-Week Low | $173.35 | $161.37 |
Typical Hold Time | 99 Days | 15 Days |
Enterprise Value | $92.38B | $32.00B |
Dividend Yield | 4.5% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPG trades at $199.61, down 1.06% on the day, amid a bearish technical setup with resistance near $200 and support at $195. Fundamentally, the REIT shows strong profitability with a net income margin of 66.57% and a P/E of 13.94, while recent news highlights leasing strength and a new media network launch. Cash flow trends show operational stability but negative net cash flow in 2025.
The outlook is mixed: analyst consensus is a Buy with a $222.90 price target, but technical indicators signal caution. Opportunities include high profitability and dividend yield; risks involve debt maturities and interest rate sensitivity. The stock offers value if operational momentum continues, but investors should weigh near-term technical pressure.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
